NCT05270395Completed
Piloting 'mPal,' a Multilevel Strategy for Palliative Care Implementation
Piloting 'mPal,' a Multilevel Implementation Strategy to Integrate Non-hospice Palliative Care Into Advanced Stage Lung Cancer Treatment
Source: ClinicalTrials.gov · Last updated 13 May 2025
Brief summary (registry, in English)
The purpose of this study is to assess the feasibility and acceptability of mPal, a multilevel implementation strategy to improve palliative care use among advanced stage lung cancer patients receiving cancer treatment.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 75 (actual)
- First submitted
- 1 Feb 2022
- Start date
- 28 Jul 2022
- Primary completion date
- 22 Mar 2024
- Lead sponsor
- Laurie McLouth
- Diseases
- Lung cancer
- NCT number
- NCT05270395
What you commit to
- Study type: Interventional
- Participants enrolled: 75
- From 28 Jul 2022 to the primary completion date, 22 Mar 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Receiving palliative care
Other illness
- Cognitive (i.e., dementia) or psychiatric condition (e.g., psychotic disorder) for which participating would be inappropriate
Other
- unstable brain metastases
- Unable to speak and read English
Who the study is looking for
- new or recurrent AJCC stage IIIb-IV non-small cell lung cancer or extensive stage small cell lung cancer
- ECOG performance status 0-3/Karnofsky 40-100
- at least three weeks into active oncologic treatment (chemotherapy, immunotherapy, chemo-immunotherapy)
Age in the registry: 18 years to 100 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Kentucky Coordinator of this site? Confirm its status | Lexington | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.